Cargando…

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

BACKGROUND: Empagliflozin has been reported to protect endothelial cell function, regardless of diabetes status. However, the role of empagliflozin in microvascular protection during myocardial ischemia reperfusion injury (I/R) has not been fully understood. METHODS: Electron microscopy, western blo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Rongjun, Shi, Wanting, Qiu, Junxiong, Zhou, Na, Du, Na, Zhou, Hao, Chen, Xinxin, Ma, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202214/ https://www.ncbi.nlm.nih.gov/pubmed/35705980 http://dx.doi.org/10.1186/s12933-022-01532-6

Ejemplares similares

SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways
por: Ma, Li, et al.
Publicado: (2022)

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway
por: Cai, Chen, et al.
Publicado: (2022)

SERCA Overexpression Improves Mitochondrial Quality Control and Attenuates Cardiac Microvascular Ischemia-Reperfusion Injury
por: Tan, Ying, et al.
Publicado: (2020)

Pathological Roles of Mitochondrial Oxidative Stress and Mitochondrial Dynamics in Cardiac Microvascular Ischemia/Reperfusion Injury
por: Zhou, Hao, et al.
Publicado: (2020)

Ndufs1 Deficiency Aggravates the Mitochondrial Membrane Potential Dysfunction in Pressure Overload-Induced Myocardial Hypertrophy
por: Zou, Rongjun, et al.
Publicado: (2021)

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
por: Hu, Zhaoyang, et al.
Publicado: (2021)

Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288]
por: Cai, Chen, et al.
Publicado: (2023)

NDUFV1 attenuates renal ischemia–reperfusion injury by improving mitochondrial homeostasis
por: Li, Lu, et al.
Publicado: (2023)

Activation of Autophagic Flux Maintains Mitochondrial Homeostasis during Cardiac Ischemia/Reperfusion Injury
por: He, Lihao, et al.
Publicado: (2022)

Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats
por: Seefeldt, Jacob Marthinsen, et al.
Publicado: (2021)

Protective effect of HINT2 on mitochondrial function via repressing MCU complex activation attenuates cardiac microvascular ischemia–reperfusion injury
por: Li, Su, et al.
Publicado: (2021)

Empagliflozin protects against renal ischemia/reperfusion injury in mice
por: Wang, Qifeng, et al.
Publicado: (2022)

Empagliflozin Enhances Autophagy, Mitochondrial Biogenesis, and Antioxidant Defense and Ameliorates Renal Ischemia/Reperfusion in Nondiabetic Rats
por: Ala, Moein, et al.
Publicado: (2022)

Combination of Linagliptin and Empagliflozin Preserves Cardiac Systolic Function in an Ischemia-Reperfusion Injury Mice With Diabetes Mellitus
por: Ideishi, Akihito, et al.
Publicado: (2021)

Mitophagy alleviates ischemia/reperfusion-induced microvascular damage through improving mitochondrial quality control
por: Wu, Dan, et al.
Publicado: (2022)

Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
por: Zhou, Hao, et al.
Publicado: (2017)

Vitamin D Attenuates Ischemia/Reperfusion-Induced Cardiac Injury by Reducing Mitochondrial Fission and Mitophagy
por: Lee, Tzu-Lin, et al.
Publicado: (2020)

Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia–reperfusion injury
por: Wang, Jin, et al.
Publicado: (2020)

Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin
por: Juni, Rio P., et al.
Publicado: (2019)

Perspectives on mitochondrial relevance in cardiac ischemia/reperfusion injury
por: Pedriali, Gaia, et al.
Publicado: (2022)

Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice
por: Tu, Yimin, et al.
Publicado: (2022)

Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats
por: Koc, Suleyman, et al.
Publicado: (2022)

The Role of PPARα in Metformin-Induced Attenuation of Mitochondrial Dysfunction in Acute Cardiac Ischemia/Reperfusion in Rats
por: Barreto-Torres, Giselle, et al.
Publicado: (2012)

DRP1 haploinsufficiency attenuates cardiac ischemia/reperfusion injuries
por: Bouche, Laura, et al.
Publicado: (2021)

LATS2 Deletion Attenuates Myocardial Ischemia-Reperfusion Injury by Promoting Mitochondrial Biogenesis
por: Chen, Yi, et al.
Publicado: (2021)

Microvascular Leakage as Therapeutic Target for Ischemia and Reperfusion Injury
por: Kloka, Jan Andreas, et al.
Publicado: (2023)

Pathogenesis of cardiac ischemia reperfusion injury is associated with CK2α-disturbed mitochondrial homeostasis via suppression of FUNDC1-related mitophagy
por: Zhou, Hao, et al.
Publicado: (2018)

Transmembrane BAX inhibitor motif containing 6 suppresses presenilin-2 to preserve mitochondrial integrity after myocardial ischemia-reperfusion injury
por: Ma, Li, et al.
Publicado: (2023)

Empagliflozin improves renal ischemia–reperfusion injury by reducing inflammation and enhancing mitochondrial fusion through AMPK–OPA1 pathway promotion
por: Yang, Wenbo, et al.
Publicado: (2023)

Mitochondrial Approaches to Protect Against Cardiac Ischemia and Reperfusion Injury
por: Camara, Amadou K. S., et al.
Publicado: (2011)

The Role of Mitochondrial Quality Control in Cardiac Ischemia/Reperfusion Injury
por: Huang, Jia, et al.
Publicado: (2021)

Cardiac Microvascular Barrier Function Mediates the Protection of Tongxinluo against Myocardial Ischemia/Reperfusion Injury
por: Qi, Kang, et al.
Publicado: (2015)

Overexpression of Activating Transcription Factor 3 Alleviates Cardiac Microvascular Ischemia/Reperfusion Injury in Rats
por: Liu, Yi, et al.
Publicado: (2021)

Mitochondrial Damage in Myocardial Ischemia/Reperfusion Injury and Application of Natural Plant Products
por: Su, Xin, et al.
Publicado: (2022)

Phosphoglycerate mutase 5 exacerbates cardiac ischemia-reperfusion injury through disrupting mitochondrial quality control
por: Zhu, Hang, et al.
Publicado: (2020)

Mitochondrial Transplantation Attenuates Cerebral Ischemia-Reperfusion Injury: Possible Involvement of Mitochondrial Component Separation
por: Xie, Qiang, et al.
Publicado: (2021)

Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis
por: Wang, Shulin, et al.
Publicado: (2015)

Growth differentiation factor 11 attenuates cardiac ischemia reperfusion injury via enhancing mitochondrial biogenesis and telomerase activity
por: Chen, Lin, et al.
Publicado: (2021)

Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury
por: Chang, Yoon-Kyung, et al.
Publicado: (2016)

Mitochondrial targets for volatile anesthetics against cardiac ischemia-reperfusion injury
por: Agarwal, Bhawana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ovsd866p10re3sqpe4p08hl70p